Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

BACKGROUND: Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil. To date, there have been relatively few articles comparing RT and propofol for general anesthesia. This study aimed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wenchen, Sun, Minli, Wan, Jie, Zhang, Zhenyu, Huang, Jian, Zhang, Jinlin, Xiong, Wanxia, Xia, Lirong, Xu, Peiyao, Miao, Changhong, Zhang, Xuesong, Liu, Mingyue, Zhong, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214677/
https://www.ncbi.nlm.nih.gov/pubmed/37237331
http://dx.doi.org/10.1186/s12871-023-02092-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214677/
https://www.ncbi.nlm.nih.gov/pubmed/37237331
http://dx.doi.org/10.1186/s12871-023-02092-2

Ejemplares similares